Approximately four in five people living with hepatitis B and three out of four people with hepatitis C infection across the European Union and European Economic Area (EU/EEA) and the UK have not yet been diagnosed. This is a major obstacle on the way towards the Sustainable Development Goal (SDG) for health in 2030 as highlighted by ECDC on occasion of World Hepatitis Day.
The first report monitoring the progress towards the elimination of hepatitis B and C across European Union (EU) and European Economic Area (EEA) countries has been published by ECDC.
This document summarises evidence from studies included in the licensing file of HPV vaccines together with postlicensure, peer-reviewed data and analysis where available. This guidance does not address the safety of HPV vaccines observed during the pre- and post-licensing period.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 15-21 December 2019 and includes updates on Ebola virus disease, dengue, chikungunya, influenza, cholera, and polio.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 17-23 November 2019 and includes updates on chikungunya, dengue, Ebola virus disease, influenza, West Nile virus and Polio.